InvestSMART

Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)

ALERT: Price-sensitive ASX Announcement for FPH
Current share price for FPH : $36.310 2.19 (6.42%)+
Announcement
Release
28 May 2025 7:31AM
Price at Release
$34.120
Full Release
download
Summary
Fisher & Paykel Healthcare Corporation Limited (FPH) has released its preliminary final report for the year ended 31 March 2024. The report details financial performance, operational highlights, strategic developments, and future outlook. FPH reported a solid revenue increase and underlying profit growth, driven by strong demand in hospital and homecare product groups, particularly in respiratory and acute care. The company continued to invest in research and development, facility expansions, and global infrastructure to support long-term growth. Despite challenges such as supply chain disruptions and fluctuating currency rates, FPH maintained a positive outlook for ongoing product innovation and global market expansion. The report provides comprehensive financial statements, governance updates, and strategic priorities for the upcoming year.
Key Points
  • Reported revenue growth and underlying profit increase for the year ended 31 March 2024.
  • Strong performance driven by demand in hospital and homecare product segments.
  • Ongoing investment in research, development, and global infrastructure.
  • Expansion of manufacturing facilities and distribution capabilities.
  • Challenges faced included supply chain issues and currency volatility.
  • Continued focus on new product development and innovation.
  • Positive outlook for sustained long-term growth.
  • Comprehensive financial and governance disclosures provided.
  • Strategic priorities highlighted for the next fiscal year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.